Quantcast
Viewing all articles
Browse latest Browse all 4824

NeuroCytonix Launches Clinical Trial Studying Its NeuroCytotron Protocol for Autism

The NeuroCytotron utilizes non-invasive, safe tissue engineering technology to stimulate proteins that aid in the regeneration of brain cells. ROCKVILLE, Md., July 3, 2024 /PRNewswire-PRWeb/ -- NeuroCytonix, Inc., today announced that on May 27, 2024, its subsidiary NeuroCytonix Mexico...


Viewing all articles
Browse latest Browse all 4824

Trending Articles